ZILBRYSQ® For Treatment Of gMG

Meta Data Analysis

Description	ZILBRYSQ® (zilucoplan) Injection is the first FDA-approved self-administered complement C5 inhibitor for the treatment of adult patients with anti-AChR Ab+ gMG.
h1 tags	The power to take charge of gMG—⁠every day1,2 For US Healthcare Professionals Only
h2 tags	Statistically significant differences Improvement observed at Week 1 Self-administered at home or away You are now leaving ZILBRYSQHCP.com.
Site Speed	0.50655388832092

Alexa Rank:	0
Site's Traffic

Host	Type	Class	TTL	Target
zilbrysqhcp.com	HINFO	IN	300